Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial

Intensive Care Medicine

Volumn 41, Issue 6, 2015, Pages 975-984

  Payen, Didier M ^a,b   Guilhot, Joelle ^c   Launey, Yoann ^d   Lukaszewicz, Anne Claire ^a,b   Kaaki, Mahmoud ^e   Veber, Benoit ^f   Pottecher, Julien ^g   Joannes Boyau, Olivier ^h   Martin Lefevre, Laurent ⁱ   Jabaudon, Matthieu ^j   Mimoz, Olivier ^c   Coudroy, Rémi ^c   Ferrandière, Martine ^k   Kipnis, Eric ^l   Vela, Carlos ^m   Chevallier, Stéphanie ⁿ   Mallat, Jihad ⁱ   Robert, René ^c  

^a HÔPITAL LARIBOISIÈRE   (France)

^b INSERM   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

^d PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^e Roanne Hospital   (France)

^f HÔPITAL CHARLES NICOLLE   (France)

^g HÔPITAL CIVIL   (France)

^h HAUT LÉVÊQUE HOSPITAL   (France)

ⁱ Medical Surgical Intensive Care   (France)

^j UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^k SERVICE DE DERMATOLOGIE   (France)

^l UNIV LILLE   (France)

^m LILLE UNIVERSITY HOSPITAL   (France)

ⁿ Saint Jean Hospital   (France)

more..

Author keywords

Hemoperfusion; Peritonitis; Polymyxin B; Septic shock

Indexed keywords

POLYMYXIN B; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; EMERGENCY SURGERY; FEMALE; HEMOPERFUSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERITONITIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; CLINICAL TRIAL; HEMODYNAMICS; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PHYSIOLOGY; PROCEDURES; SHOCK, SEPTIC; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FEMALE; HEMODYNAMICS; HEMOPERFUSION; HUMANS; MALE; MIDDLE AGED; MORTALITY; MULTIPLE ORGAN FAILURE; PERITONITIS; POLYMYXIN B; PROSPECTIVE STUDIES; SHOCK, SEPTIC; YOUNG ADULT;

EID: 84931957864     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-015-3751-z     Document Type: Article

References (22)

1. Liu V, Escobar GJ, Greene JD, Soule J, Whippy A, Angus DC, Iwashyna TJ (2014) Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA 312:90–92
2. Koperna T, Schulz F (1996) Prognosis and treatment of peritonitis. Do we need new scoring systems? Arch Surg 131:180–186
3. Riche FC, Dray X, Laisne MJ, Mateo J, Raskine L, Sanson-Le Pors MJ, Payen D, Valleur P, Cholley BP (2009) Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis. Crit Care 13:R99
4. Opal SM, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP, Wittebole X, Dugernier T, Perrotin D, Tidswell M, Jauregui L, Krell K, Pachl J, Takahashi T, Peckelsen C, Cordasco E, Chang CS, Oeyen S, Aikawa N, Maruyama T, Schein R, Kalil AC, Van Nuffelen M, Lynn M, Rossignol DP, Gogate J, Roberts MB, Wheeler JL, Vincent JL (2013) Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA 309:1154–1162
5. Losser MR, Bernard C, Beaudeux JL, Pison C, Payen D (1997) Glucose modulates hemodynamic, metabolic, and inflammatory responses to lipopolysaccharide in rabbits. J Appl Physiol 83:1566–1574
6. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG, Lowry SF (2005) A network-based analysis of systemic inflammation in humans. Nature 437:1032–1037
7. McCloskey RV, Straube RC, Sanders C, Smith SM, Smith CR (1994) Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group. Ann Intern Med 121:1–5
8. Joannes-Boyau O, Honore PM, Perez P, Bagshaw SM, Grand H, Canivet JL, Dewitte A, Flamens C, Pujol W, Grandoulier AS, Fleureau C, Jacobs R, Broux C, Floch H, Branchard O, Franck S, Roze H, Collin V, Boer W, Calderon J, Gauche B, Spapen HD, Janvier G, Ouattara A (2013) High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med 39:1535–1546
9. Payen D, Mateo J, Cavaillon JM, Fraisse F, Floriot C, Vicaut E, Hemofiltration, Sepsis Group of the College National de Reanimation et de Medecine d’Urgence des Hopitaux e-U (2009) Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial. Crit Care Med 37:803–810
10. Vincent JL, Laterre PF, Cohen J, Burchardi H, Bruining H, Lerma FA, Wittebole X, De Backer D, Brett S, Marzo D, Nakamura H, John S (2005) A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 23:400–405
11. Nakamura T, Ebihara I, Shoji H, Ushiyama C, Suzuki S, Koide H (1999) Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: decrease in plasma levels of soluble P-selectin, platelet factor 4 and beta-thromboglobulin. Inflamm Res 48:171–175
12. Nakamura T, Kawagoe Y, Suzuki T, Shoji H, Ueda Y, Koide H (2007) Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock. Am J Med Sci 334:244–247
13. Nemoto H, Nakamoto H, Okada H, Sugahara S, Moriwaki K, Arai M, Kanno Y, Suzuki H (2001) Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis. Blood Purif 19:361–368 (discussion 368–369)
14. Shoji H (2003) Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin). Ther Apher Dial 7:108–114
15. Suzuki H, Nemoto H, Nakamoto H, Okada H, Sugahara S, Kanno Y, Moriwaki K (2002) Continuous hemodiafiltration with polymyxin-B immobilized fiber is effective in patients with sepsis syndrome and acute renal failure. Ther Apher 6:234–240
16. Cruz DN, Perazella MA, Bellomo R, de Cal M, Polanco N, Corradi V, Lentini P, Nalesso F, Ueno T, Ranieri VM, Ronco C (2007) Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care 11:R47
17. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C (2009) Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 301:2445–2452
18. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, International Sepsis Definitions C (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med 29:530–538
19. Scheller J, Garbers C, Rose-John S (2014) Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities. Semin Immunol 26:2–12
20. Wacha H, Hau T, Dittmer R, Ohmann C (1999) Risk factors associated with intraabdominal infections: a prospective multicenter study. Peritonitis Study Group. Langenbecks Arch Surg 384:24–32
21. Iwagami M, Yasunaga H, Doi K, Horiguchi H, Fushimi K, Matsubara T, Yahagi N, Noiri E (2014) Postoperative polymyxin B hemoperfusion and mortality in patients with abdominal septic shock: a propensity-matched analysis. Crit Care Med 42:1187–1193
22. Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, Gardlund B, Marshall JC, Rhodes A, Artigas A, Payen D, Tenhunen J, Al-Khalidi HR, Thompson V, Janes J, Macias WL, Vangerow B, Williams MD, Group P-SS (2012) Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366:2055–2064